-
Diagnostic conundrum: Classic Hodgkin Lymphoma or a mimic?Read our blog post on expert approaches to resolving challenging areas in diagnostic pathologyRead now -
The Jan-Jun 2019 alternative assessment for HER2 breast FISH is now available in NeoUniversity.Sign In Now
-
NeoGenomics Appoints Dr. Lawrence M. Weiss as Chief Scientific OfficerRead press release
-
NeoGenomics Reports 50% Revenue Growth to Record $102 Million in the Second QuarterRead press release
-
Patient BillingLearn moreNeoGenomics makes billing as flexible as possible by providing many different payment options.
-
NeoGenomics Announces Participation in NCI-MATCH
Clinical TrialRead press release -
NeoGenomics Awarded Clinical Reference Laboratory Testing Services Agreement with PremierRead press release
-
Global CapabilitiesLearn about our unique service offerings that are now available globallyRead now
-
Read our Article in Springer NatureDetecting BRAF, KRAS, and EGFR Mutations via NGS vs. PCR-based KitsRead now
-
PD-L1 22C3 (KEYTRUDA®) for ESCCLearn moreNew indication for esophageal squamous cell carcinoma
-
BRCA1/2 Mutation Analysis for TumorsLearn more
-
PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head & Neck) now availableLearn more
-
Pan-TRK IHCScreening test for NTRK1, 2, and 3 gene fusionsLearn more
-
NTRK NGS Fusion ProfileTargeted test for TRK fusion cancerLearn more